Mersana Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Mersana Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms.
Business Model
Clinical-stage biopharmaceutical company developing and commercializing antibody-drug conjugates (ADCs) for cancer treatment.
Target Customers
Cancer patients with unmet needs.
Specific Focus
Antibody-drug conjugates (ADCs) for cancer treatment, specifically targeting areas of high unmet medical need.
Location
Cambridge, Massachusetts
CEO
Martin Huber, MD
Industry
Life sciences
Sub Sector
Biopharmaceutical
3yr Revenue Growth
4,351%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Mersana Therapeutics, Inc. in the Pharmaceuticals & Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Mersana Therapeutics, Inc.? Our platform provides detailed analysis of Mersana Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Mersana Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Mersana Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals & Biotechnology sector, Mersana Therapeutics, Inc. operates in the specialized Biopharmaceutical sub-sector. Understanding how Mersana Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceutical space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Super.com
Fintech • Fintech
Super.com is a fintech company offering a "savings super app" that combines travel deals, cashback rewards, and credit-building tools. It helps users save money, earn cash, and build credit through various features such as discounted hotel bookings, cash advances, cashback on purchases, and opportunities to earn money through games and surveys. The company targets individuals with low-to-medium FICO scores and limited access to premium financial services.
Dragos
Technology • Software & services
Dragos is an industrial cybersecurity company with a global mission to safeguard civilization by protecting critical infrastructure from cyber threats. They provide technology and services for industrial control systems (ICS) and operational technology (OT) environments, leveraging threat intelligence and industry expertise.
Trullion
Fintech • Fintech
Trullion is an AI-powered accounting platform that automates financial workflows for finance teams, accountants, and auditors, enhancing efficiency, accuracy, and collaboration. It offers solutions for lease accounting, revenue recognition, and audit automation, providing a single source of truth for financial data.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Mersana Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free